Safety of Postoperative Concurrent Capecitabine and Intensity-Modulated Radiotherapy in Triple-Negative Breast Cancer: Results from a Phase II Prospective Study
International Journal of Radiation Oncology*Biology*Physics · 2026-09 · 126 (1) · S177
DOI: 10.1016/j.ijrobp.2026.06.377 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-09. Verfasst von J. Li und 19 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Li, J., Zhai, Y., Lan, B., Wang, Y., Zhou, L., Song, Y., Zhao, X., Chen, S., Sun, G., Fang, H., Chen, B., Yang, Z., Lu, N., Qi, S., Jing, H., Tang, Y., Zhang, W., Li, Y., Ma, F., & Wang, S. (2026). Safety of Postoperative Concurrent Capecitabine and Intensity-Modulated Radiotherapy in Triple-Negative Breast Cancer: Results from a Phase II Prospective Study. International Journal of Radiation Oncology*Biology*Physics, 126(1), S177. https://doi.org/10.1016/j.ijrobp.2026.06.377
Vancouver
Li J, Zhai Y, Lan B, Wang Y, Zhou L, Song Y, et al. Safety of Postoperative Concurrent Capecitabine and Intensity-Modulated Radiotherapy in Triple-Negative Breast Cancer: Results from a Phase II Prospective Study. International Journal of Radiation Oncology*Biology*Physics. 2026;126(1):S177. doi:10.1016/j.ijrobp.2026.06.377
BibTeX
@article{Li2026,
author = {Li, J. and Zhai, Y. and Lan, B. and Wang, Y. and Zhou, L. and Song, Y. and Zhao, X. and Chen, S. and Sun, G. and Fang, H. and Chen, B. and Yang, Z. and Lu, N. and Qi, S. and Jing, H. and Tang, Y. and Zhang, W. and Li, Y.X. and Ma, F. and Wang, S.L.},
title = {Safety of Postoperative Concurrent Capecitabine and Intensity-Modulated Radiotherapy in Triple-Negative Breast Cancer: Results from a Phase II Prospective Study},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {126},
number = {1},
pages = {S177},
doi = {10.1016/j.ijrobp.2026.06.377}
}
EUVIMED